CD70 encoded by modified vaccinia virus Ankara enhances CD8 T‐cell‐dependent protective immunity in MHC class II‐deficient mice

Abstract

SummaryThe immunological outcome of infections and vaccinations is largely determined during the initial first days in which antigen‐presenting cells instruct T cells to expand and differentiate into effector and memory cells. Besides the essential stimulation of the T‐cell receptor complex a plethora of co‐stimulatory signals not only ensures a proper T‐cell activation but also instils phenotypic and functional characteristics in the T cells appropriate to fight off the invading pathogen. The tumour necrosis factor receptor/ligand pair CD27/CD70 gained a lot of attention because of its key role in regulating T‐cell activation, survival, differentiation and maintenance, especially in the course of viral infections and cancer. We sought to investigate the role of CD70 co‐stimulation for immune responses induced by the vaccine vector modified vaccinia virus Ankara–Bavarian Nordic® (MVA‐BN ®). Short‐term blockade of CD70 diminished systemic CD8 T‐cell effector and memory responses in mice. The dependence on CD70 became even more apparent in the lungs of MHC class II‐deficient mice. Importantly, genetically encoded CD70 in MVA‐BN ® not only increased CD8 T‐cell responses in wild‐type mice but also substituted for CD4 T‐cell help. MHC class II‐deficient mice that were immunized with recombinant MVA‐CD70 were fully protected against a lethal virus infection, whereas MVA‐BN ®‐immunized mice failed to control the virus. These data are in line with CD70 playing an important role for vaccine‐induced CD8 T‐cell responses and prove the potency of integrating co‐stimulatory molecules into the MVA‐BN ® backbone.

Evaluation of the Effect of CD70 Co-Expression on CD8 T Cell Response in Protein-Prime MVA-Boost Vaccination in Mice

“…Bathke et al [ 58 ] designed rMVA-CD70 constructs for homologous prime-boost experiments and observed that CD8 T cell responses against the MVA epitope B8R were stronger after CD70 co-expression via two rMVA immunizations than those against the target transgene—ovalbumin (OVA). Such misdirected effects could lead to unspecific and harmful immune reactions.…”

The Journey of in vivo Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road

“…Interestingly, preclinical efficacy of MVA was mainly attributed to CD4 + T cells and polyclonal h5T4-specific antibodies, as only weak CD8 + T cell responses were induced ( 50 ). Therefore, the addition of stimulatory immune checkpoints like inclusion of CD70 or mGITRL-fusion proteins has been tested preclinically to enhance CTL responses ( 51 ). More robust tumor regression with improved overall survival was reported when using viral vectors encoding mGITRL-fusion proteins.…”

Establishment and validation of a novel risk model based on CD8T cell marker genes to predict prognosis in thyroid cancer by integrated analysis of single-cell and bulk RNA-sequencing

“…[ 17 ] The cytotoxicity of CD8T cells is influenced by transcription factors and receptor/ligand pair. [ 18 , 19 ] For instance, a recent study revealed that Interleukin 2 treatment has the potential to enhance the function of CD8T cells. [ 20 ] In addition, the upregulation of C-X-C motif chemokine receptor 3 expression, a chemokine receptor, could promote the recognition of targets in CD8T cells.…”